RELV Stock Overview
Reliv’ International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Reliv' International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.85 |
| 52 Week High | US$4.34 |
| 52 Week Low | US$2.09 |
| Beta | 0 |
| 1 Month Change | -3.75% |
| 3 Month Change | -2.04% |
| 1 Year Change | 5.48% |
| 3 Year Change | 6.65% |
| 5 Year Change | -12.50% |
| Change since IPO | -90.88% |
Recent News & Updates
Shareholder Returns
| RELV | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 1.3% | 3.2% | -3.2% |
| 1Y | 5.5% | -32.6% | 19.3% |
Return vs Industry: RELV exceeded the US Personal Products industry which returned -32.6% over the past year.
Return vs Market: RELV underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| RELV volatility | |
|---|---|
| RELV Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RELV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RELV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Ryan Montgomery | www.reliv.com |
Reliv’ International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company’s basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules.
Reliv' International, Inc. Fundamentals Summary
| RELV fundamental statistics | |
|---|---|
| Market cap | US$5.47m |
| Earnings (TTM) | -US$175.47k |
| Revenue (TTM) | US$35.13m |
0.0x
P/S Ratio0.0x
P/E RatioIs RELV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RELV income statement (TTM) | |
|---|---|
| Revenue | US$35.13m |
| Cost of Revenue | US$9.50m |
| Gross Profit | US$25.62m |
| Other Expenses | US$25.80m |
| Earnings | -US$175.47k |
Last Reported Earnings
Sep 30, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did RELV perform over the long term?
See historical performance and comparison